$148.21
-$1.07(-0.71%)
*Data last updated: 2026-08-15 07:34 (UTC+8)
As of 2026-08-15 07:34, Agilent Technologies Inc (A) is priced at $148.21, with a total market cap of $39.13B, a P/E ratio of 31.88, and a dividend yield of 0.73%. Today, the stock price fluctuated between $146.90 and $148.92. The current price is 0.89% above the day's low and 0.47% below the day's high, with a trading volume of 1.12M. Over the past 52 weeks, A has traded between $108.95 to $152.54, and the current price is -2.83% away from the 52-week high.
Key Stats
Yesterday's Close$139.74
Market Cap$39.13B
Volume1.12M
P/E Ratio31.88
Dividend Yield (TTM)0.73%
Dividend Amount$0.25
Diluted EPS (TTM)4.99
Net Income (FY)$1.30B
Revenue (FY)$6.94B
Earnings Date2026-08-26
EPS Estimate1.49
Revenue Estimate$1.84B
Shares Outstanding280.06M
Beta (1Y)1.255
Ex-Dividend Date2026-06-30
Dividend Payment Date2026-07-22
Introduction
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOPadraig McDonnell
HeadquartersSanta Clara,CA,US
Official Websitehttps://www.agilent.com
Employees (FY)18.10K
Average Revenue (1Y)$383.86K
Net Income per Employee$71.98K
Learn
Blogs
SMIC Shares Surge Over 5%: Can a 25.3% Gross Margin Justify Its High Valuation?SMIC Reports Q2 Revenue of $3.006 Billion, Beats Expectations With Gross Margin at 25.3%; Q3 Margin Guidance Further Raised to 26%-28%. This article breaks down the structural shifts driving simultaneous growth in both sales volume and average selling price. It examines how the spillover demand from AI and rising domestic orders are impacting SMIC’s valuation. Key metrics for ong2026-08-14

Can BANANAS31 Price Keep Rising? Banana For Scale Meme Momentum, Market Trends, and Future OutlookBANANAS31 price has recently gained attention after a strong rally. Explore why BANANAS31 is rising, how Meme coin momentum affects its price, and the key factors shaping its future outlook in 2026.2026-08-14

SanDisk Soars 455% in 2026: Can $93.9 Billion in Long-Term Contracts Underpin a New AI Storage Thesis?SanDisk (SNDK) surged over 455% in 2026, with Investor Day revealing $93.9 billion in long-term agreements and the HBF sample initiative. This article examines how AI-driven inference is reshaping NAND valuation logic, and highlights the performance delivery risks that investors should monitor amid high expectations.2026-08-14

A FAQ
What's the stock price of Agilent Technologies Inc (A) today?
x
Agilent Technologies Inc (A) is currently trading at $148.21, with a 24h change of -0.71%. The 52-week trading range is $108.95–$152.54.
What are the 52-week high and low prices for Agilent Technologies Inc (A)?
x
What is the price-to-earnings (P/E) ratio of Agilent Technologies Inc (A)? What does it indicate?
x
What is the market cap of Agilent Technologies Inc (A)?
x
What is the most recent quarterly earnings per share (EPS) for Agilent Technologies Inc (A)?
x
Should you buy or sell Agilent Technologies Inc (A) now?
x
What factors can affect the stock price of Agilent Technologies Inc (A)?
x
How to buy Agilent Technologies Inc (A) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.






